158 related articles for article (PubMed ID: 6820875)
1. [MQF-OK therapy in advanced terminal stomach cancer--with special reference to a comparison with MFC therapy].
Sakata Y; Yoshida Y; Komatsu Y; Sugawara K; Nishimura S; Kikuchi K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):109-15. PubMed ID: 6820875
[TBL] [Abstract][Full Text] [Related]
2. [Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy].
Sakata Y; Munakata A; Baba T; Saitoh S; Itoh T; Tamura Y; Furukohori N; Suzuki H; Kimura T; Kawata K
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2065-71. PubMed ID: 3134859
[TBL] [Abstract][Full Text] [Related]
3. [MQF-FT and MQF-UFT in gallbladder and bile duct cancer].
Sakata Y; Fukushi G; Tsushima K; Suzuki H; Kimura T; Kimura M; Tamura Y; Kishibe T; Saitoh S; Itoh T
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2731-5. PubMed ID: 3137889
[TBL] [Abstract][Full Text] [Related]
4. [Combination chemotherapy of mitomycin-C, carboquone, 5-fluorouracil and OK-432 for inoperable gastric cancer (author's transl)].
Sakata Y; Sugawara K; Komatsu Y; Yoshida Y; Nishimura S; Kikuchi K
Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):978-87. PubMed ID: 541534
[No Abstract] [Full Text] [Related]
5. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer.
Cocconi G; DeLisi V; Di Blasio B
Cancer Treat Rep; 1982 Jun; 66(6):1263-6. PubMed ID: 7083233
[TBL] [Abstract][Full Text] [Related]
6. [A randomized controlled trial of surgical adjuvant therapy with mitomycin C, 5-fluorouracil and OK-432 in patients with gastric cancer].
Yamamura Y; Nishimura M; Sakamoto J; Yasui K; Morimoto T; Kato T; Yasue M; Kito T; Miyaishi S; Nakazato H
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2134-40. PubMed ID: 3087293
[TBL] [Abstract][Full Text] [Related]
7. [Pre-operative chemotherapy of stomach cancer combined with local administration of OK-432--evaluation of macroscopic results].
Mukai M; Den N; Yamazaki Y; Namiki S; Oda S; Nagao K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):96-102. PubMed ID: 6820880
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant immunochemotherapy combined with OK-432 following surgery of stomach cancer].
Yamamura Y; Yasue M; Kito T; Nakazato H; Yamada E
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1603-9. PubMed ID: 6409009
[TBL] [Abstract][Full Text] [Related]
9. Treatment of gastric cancer, with special reference to the survivals of the cancer patients treated with multiple combination MFC therapy or immunochemotherapy of MFC plus OK-432 (NSC B116209).
Suga S; Tsunekawa H; Washino M; Makino N; Tamura Z; Goto S
Gastroenterol Jpn; 1977; 12(2):20-9. PubMed ID: 892332
[TBL] [Abstract][Full Text] [Related]
10. [Preoperative combination therapy involving local administration of a non-specific immunoactivated preparation (OK-432) and chemotherapeutic preparations for patients with stomach cancer].
Mukai M; Ryu S; Kikuchi T; Ariga T; Nagashima T; Koh Z; Yamazaki Y; Odaka M; Satoh H; Nagao K
Gan To Kagaku Ryoho; 1985 Apr; 12(4):880-6. PubMed ID: 3920972
[TBL] [Abstract][Full Text] [Related]
11. [A case with gastric cancer by OK-MF'C therapy (author's transl)].
Tomomatsu H; Morita N; Nagai T; Shiwaku Y; Shingami T; Miura Y; Kihara K; Nakao Y; Shimokawahara H; Hashimoto S; Yunoki K
Igaku Kenkyu; 1979 Sep; 49(3):268-76. PubMed ID: 547643
[No Abstract] [Full Text] [Related]
12. [Chemotherapy of unresectable Borrmann's type IV stomach cancer].
Kurihara M; Izumi T; Sasaki Y; Maruyama T; Miyasaka K
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2468-77. PubMed ID: 6418075
[TBL] [Abstract][Full Text] [Related]
13. [The significance of endoscopic treatment of early gastric cancer].
Nashimoto A; Maeda C; Sasaki K; Muto T
Nihon Geka Gakkai Zasshi; 1988 May; 89(5):655-63. PubMed ID: 3412299
[TBL] [Abstract][Full Text] [Related]
14. [Preoperative OMF therapy for gastric cancer--examination of macroscopical effect in comparison with histological effect].
Mukai M; Hiura T; Yamazaki Y; Namiki S; Nagao K
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1801-7. PubMed ID: 6820884
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of urothelial cancer with vincristine, mitomycin C, bleomycin, tegafur and OK-432].
Fujihiro S; Takeuchi T; Fujimoto Y; Okano M; Horie M; Kanematsu M; Kuriyama M; Ban Y; Nishiura T
Gan To Kagaku Ryoho; 1984 Mar; 11(3):427-32. PubMed ID: 6200077
[TBL] [Abstract][Full Text] [Related]
16. [Preoperative immunochemotherapy for gastric cancer combined with perifocal administration of OK-432].
Mukai M; Yamazaki Y; Amano H; Hiura T; Oda S; Namiki S; Nakajima K; Nagao K
Gan To Kagaku Ryoho; 1984 May; 11(5):1071-7. PubMed ID: 6426402
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of immunochemotheray on advanced gastric cancer--combination of OK-432 (picibanil), mitomycin C, and 5-fluorouracil (MF-O therapy) (author's transl)].
Nio Y; Nakamoto K; Tanaka A; Kikuchi S; Henmi K
Nihon Gan Chiryo Gakkai Shi; 1980 Apr; 15(2):161-5. PubMed ID: 7400644
[No Abstract] [Full Text] [Related]
18. Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/OK-432 (MQ-F-OK) therapy and mitomycin C/5-fluorouracil/doxorubicin (FAM) therapy against advanced liver cancer.
Sakata Y; Komatsu Y; Takagi S; Saitoh S; Itoh T; Suzuki H; Tsushima K; Sasaki D; Yoshida Y
Cancer Chemother Pharmacol; 1989; 23 Suppl():S9-12. PubMed ID: 2647315
[TBL] [Abstract][Full Text] [Related]
19. [Randomized controlled study of OK-432 in the treatment of cancerous pleurisy].
Urata A; Nishimura M; Ota K
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1497-503. PubMed ID: 6409006
[TBL] [Abstract][Full Text] [Related]
20. [A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (internal medicine group evaluation)].
Kitamura S; Ohtani T; Kurihara M; Kosaki G; Akazawa S; Sasaki T; Takahashi H; Nakano S; Tokunaga K
Gan To Kagaku Ryoho; 1995 May; 22(6):765-75. PubMed ID: 7755384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
